Zkusit zdarma
Aadi Bioscience, Inc.

Aadi Bioscience, Inc.

AADI
Cena:
 
 
Valuace
70
Růst
53
Zdraví
50
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Aadi Bioscience (NASDAQ:AADI) and Ayala Pharmaceuticals (NASDAQ:ADXS) Head to Head Analysis

Aadi Bioscience (NASDAQ:AADI) and Ayala Pharmaceuticals (NASDAQ:ADXS) Head to Head Analysis

1:28 28-03-2026

Insider and Institutional Ownership 7.2% of Ayala Pharmaceuticals shares are owned by institutional ...

Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027

Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027

2:02 12-03-2026

Whitehawk Therapeutics CEO Dave Lennon outlined the company's strategy and near-term milestones at t...

Aadi Bioscience Conference: Whitehawk CEO Details 3-Program ADC Pipeline, First Data Seen in 2027

Aadi Bioscience Conference: Whitehawk CEO Details 3-Program ADC Pipeline, First Data Seen in 2027

2:34 05-03-2026

Whitehawk Therapeutics CEO Dave Lennon presented at TD Cowen's 46th Annual Healthcare Conference, ou...

Aadi Bioscience (NASDAQ:AADI) versus Nabriva Therapeutics (NASDAQ:NBRV) Head-To-Head Analysis

Aadi Bioscience (NASDAQ:AADI) versus Nabriva Therapeutics (NASDAQ:NBRV) Head-To-Head Analysis

3:12 28-01-2026

Profitability This table compares Aadi Bioscience and Nabriva Therapeutics' net margins, return on e...

Aadi Bioscience (NASDAQ:AADI) vs. Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Survey

Aadi Bioscience (NASDAQ:AADI) vs. Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Survey

2:10 04-01-2026

Risk and Volatility Eagle Pharmaceuticals has a beta of 0.83, meaning that its share price is 17% le...

Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update

Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update

8:00 14-03-2025

MORRISTOWN, N.J. , March 14, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi") tod...

Aadi Bioscience, Inc. (AADI) Expected to Beat Earnings Estimates: Should You Buy?

Aadi Bioscience, Inc. (AADI) Expected to Beat Earnings Estimates: Should You Buy?

11:00 05-03-2025

Aadi Bioscience (AADI) possesses the right combination of the two key ingredients for a likely earni...

Aadi Bioscience Announces Closing of $100 Million PIPE Financing

Aadi Bioscience Announces Closing of $100 Million PIPE Financing

16:05 04-03-2025

MORRISTOWN, N.J. , March 4, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an o...

Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders

Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders

8:00 03-03-2025

MORRISTOWN, N.J. , March 3, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), an oncology t...

All You Need to Know About Aadi Bioscience (AADI) Rating Upgrade to Buy

All You Need to Know About Aadi Bioscience (AADI) Rating Upgrade to Buy

13:00 26-02-2025

Aadi Bioscience (AADI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer

8:00 18-02-2025

Seasoned Oncology Leader Brings Extensive ADC Expertise to Support Company's New Pipeline MORRISTOWN...

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025

16:05 05-02-2025

Proxy Statement Includes Proposals on Previously Announced Sale of FYARRO and Associated Infrastruct...

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?

8:43 20-12-2024

On Thursday, Aadi Bioscience, Inc.  AADI entered into an exclusive license agreement for the develo...

Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates

Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates

10:10 06-11-2024

Aadi Bioscience, Inc. (AADI) came out with a quarterly loss of $0.46 per share in line with the Zack...

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

8:00 06-11-2024

FYARRO® sales of $7.2 million for Q3 2024, reflecting 21% year over year sales growth Aadi continue...

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

16:05 30-10-2024

LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) today announced that...

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

17:00 20-08-2024

PRECISION1 tumor-agnostic trial unlikely to meet regulatory threshold to support an accelerated appr...

Aadi Bioscience, Inc. (AADI) Q2 2024 Earnings Call Transcript

Aadi Bioscience, Inc. (AADI) Q2 2024 Earnings Call Transcript

10:20 10-08-2024

Aadi Bioscience, Inc. (NASDAQ:AADI ) Q2 2024 Earnings Conference Call August 7, 2024 8:30 AM ET Comp...

Aadi Bioscience, Inc. (AADI) Reports Q2 Loss, Lags Revenue Estimates

Aadi Bioscience, Inc. (AADI) Reports Q2 Loss, Lags Revenue Estimates

10:11 07-08-2024

Aadi Bioscience, Inc. (AADI) came out with a quarterly loss of $0.54 per share versus the Zacks Cons...

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

8:00 07-08-2024

FYARRO® sales of $6.2 million for Q2 2024, a 15% quarter over quarter sales growth Interim analysis...

close

AADI BIOSCIENCE RELAUNCHES AS WHITEHAWK THERAPEUTICS MARKING EVOLUTION INTO ADC COMPANY

18-03-2025
NEW NAME REFLECTS FOCUS ON ACCELERATING PORTFOLIO OF ADVANCED ADC THERAPIES WITH SPEED, AGILITY AND ...
Více zde

AADI BIOSCIENCE TO REPORT FOURTH QUARTER AND FULL-YEAR 2024 RESULTS AND CORPORATE UPDATE

14-03-2025
MORRISTOWN, N.J. , MARCH 14, 2025 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI) ("AADI") TOD...
Více zde

AADI BIOSCIENCE ANNOUNCES CLOSING OF $100 MILLION PIPE FINANCING

04-03-2025
MORRISTOWN, N.J. , MARCH 4, 2025 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI) ("AADI"), AN O...
Více zde

AADI BIOSCIENCE ANNOUNCES APPROVAL OF ALL PROPOSALS AT SPECIAL MEETING OF STOCKHOLDERS

03-03-2025
MORRISTOWN, N.J. , MARCH 3, 2025 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI), AN ONCOLOGY T...
Více zde

AADI BIOSCIENCE TO PRESENT AT THE TD COWEN 45TH ANNUAL HEALTHCARE CONFERENCE

24-02-2025
MORRISTOWN, N.J. , FEB. 24, 2025 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI) ANNOUNCED TOD...
Více zde

AADI BIOSCIENCE APPOINTS DAVID DORNAN, PHD, AS CHIEF SCIENTIFIC OFFICER

18-02-2025
SEASONED ONCOLOGY LEADER BRINGS EXTENSIVE ADC EXPERTISE TO SUPPORT COMPANY'S NEW PIPELINE MORRISTOWN...
Více zde

AADI BIOSCIENCE FILED DEFINITIVE PROXY STATEMENT AND SCHEDULES SPECIAL MEETING OF STOCKHOLDERS FOR FEBRUARY 28, 2025

05-02-2025
PROXY STATEMENT INCLUDES PROPOSALS ON PREVIOUSLY ANNOUNCED SALE OF FYARRO AND ASSOCIATED INFRASTRUCT...
Více zde

AADI BIOSCIENCE TRANSFORMS WITH IN-LICENSING OF NOVEL ADC PORTFOLIO, $100 MILLION SALE OF FYARRO® AND $100 MILLION PIPE FINANCING

19-12-2024
AADI ENTERS INTO EXCLUSIVE LICENSE FOR THREE-ASSET ADC PORTFOLIO DEVELOPED THROUGH A COLLABORATION B...
Více zde

AADI BIOSCIENCE ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER 2024 AND PROVIDES CORPORATE UPDATE

06-11-2024
FYARRO® SALES OF $7.2 MILLION FOR Q3 2024, REFLECTING 21% YEAR OVER YEAR SALES GROWTH AADI CONTINUE...
Více zde

AADI BIOSCIENCE TO REPORT THIRD QUARTER 2024 RESULTS AND CORPORATE UPDATE

30-10-2024
LOS ANGELES, OCT. 30, 2024 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI) TODAY ANNOUNCED THAT...
Více zde

AADI BIOSCIENCE PROVIDES PRECISION1 TRIAL AND CORPORATE UPDATES

20-08-2024
PRECISION1 TUMOR-AGNOSTIC TRIAL UNLIKELY TO MEET REGULATORY THRESHOLD TO SUPPORT AN ACCELERATED APPR...
Více zde

AADI BIOSCIENCE ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER 2024 AND PROVIDES CORPORATE UPDATE

07-08-2024
FYARRO® SALES OF $6.2 MILLION FOR Q2 2024, A 15% QUARTER OVER QUARTER SALES GROWTH INTERIM ANALYSIS...
Více zde

AADI BIOSCIENCE TO REPORT SECOND QUARTER 2024 RESULTS AND CORPORATE UPDATE

31-07-2024
COMPANY TO HOST CONFERENCE CALL AND WEBCAST ON AUGUST 7, 2024 LOS ANGELES , JULY 31, 2024 /PRNEWSWI...
Více zde

AADI BIOSCIENCE TO PARTICIPATE IN THE JEFFERIES HEALTHCARE CONFERENCE

29-05-2024
LOS ANGELES , MAY 29, 2024 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI), A COMMERCIAL-STAGE...
Více zde

AADI BIOSCIENCE PRESENTS NEW NONCLINICAL DATA DEMONSTRATING PREFERENTIAL TUMOR UPTAKE OF NAB-SIROLIMUS AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

23-05-2024
NAB-SIROLIMUS DEMONSTRATED SIGNIFICANTLY GREATER INTRATUMORAL DRUG CONCENTRATION, STRONGER INHIBITIO...
Více zde

AADI BIOSCIENCE ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2024 AND PROVIDES CORPORATE UPDATE

08-05-2024
FULLY ENROLLED REGISTRATION-INTENDED PRECISION1 TRIAL;  TWO-THIRDS INTERIM ANALYSIS PLANNED FOR Q3 ...
Více zde

AADI BIOSCIENCE TO REPORT FIRST QUARTER 2024 RESULTS AND CORPORATE UPDATE

01-05-2024
COMPANY TO HOST CONFERENCE CALL AND WEBCAST ON MAY 8, 2024 LOS ANGELES , MAY 1, 2024 /PRNEWSWIRE/ -...
Více zde

AADI BIOSCIENCE TO PRESENT NEW NON-CLINICAL DATA HIGHLIGHTING COMBINABILITY OF NAB-SIROLIMUS AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING

09-04-2024
DATA FURTHER SUPPORT CLINICAL EXPLORATION OF NAB-SIROLIMUS IN COMBINATION WITH ENDOCRINE THERAPY FOR...
Více zde

AADI BIOSCIENCE PRESENTS NEW SUBGROUP ANALYSIS OF PATIENTS WITH ADVANCED MALIGNANT PECOMA OF GYNECOLOGIC ORIGIN TREATED WITH NAB-SIROLIMUS AT SOCIETY OF GYNECOLOGIC ONCOLOGY (SGO)

17-03-2024
SUBGROUP EXPERIENCED EFFICACY AND SAFETY CONSISTENT WITH OVERALL STUDY POPULATION ADVANCED MALIGNANT...
Více zde

AADI BIOSCIENCE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL-YEAR 2023 AND PROVIDES CORPORATE UPDATE

13-03-2024
FYARRO® SALES OF $6.3 MILLION FOR Q4 2023 AND $24.4 MILLION FOR FY 2023 REPRESENTING YEAR-OVER-YEAR...
Více zde

AADI BIOSCIENCE TO REPORT FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND CORPORATE UPDATE

06-03-2024
COMPANY TO HOST CONFERENCE CALL AND WEBCAST ON MARCH 13, 2024 LOS ANGELES , MARCH 6, 2024 /PRNEWSWI...
Více zde

AADI BIOSCIENCE TO PRESENT MULTIPLE POSTERS AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING 2024

05-03-2024
LOS ANGELES , MARCH 5, 2024 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI), A BIOPHARMACEUTIC...
Více zde

AADI BIOSCIENCE ANNOUNCES PUBLICATION OF LONG-TERM EFFICACY AND SAFETY DATA FURTHER SUPPORTING FYARRO® FOR THE TREATMENT OF MALIGNANT PECOMA

01-03-2024
AFTER 3 YEARS OF FOLLOW-UP IN AMPECT TRIAL, CONFIRMED CLINICALLY MEANINGFUL OVERALL RESPONSE RATE, I...
Více zde

AADI BIOSCIENCE TO PRESENT AT THE TD COWEN 44TH ANNUAL HEALTHCARE CONFERENCE

26-02-2024
LOS ANGELES , FEB. 26, 2024 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI), A BIOPHARMACEUTICA...
Více zde

AADI BIOSCIENCE ANNOUNCES POSTER PRESENTATIONS AT THE 2024 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) GENITOURINARY (GU) CANCERS SYMPOSIUM

26-01-2024
REAL-WORLD GENOMIC ANALYSIS HIGHLIGHTS UNMET MEDICAL NEED IN GU CANCER PATIENTS WITH TSC1/2 INACTIVA...
Více zde

AADI BIOSCIENCE ANNOUNCES POSTER PRESENTATIONS AT THE 2024 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) GASTROINTESTINAL (GI) CANCERS SYMPOSIUM

19-01-2024
- NEW REAL-WORLD ANALYSIS HIGHLIGHTS UNMET MEDICAL NEED IN GI CANCER PATIENTS WITH TSC1/2 ALTERATION...
Více zde

AADI BIOSCIENCE REPORTS INTERIM RESULTS FROM PRECISION1 TRIAL OF NAB-SIROLIMUS DEMONSTRATING ANTI-TUMOR ACTIVITY IN SOLID TUMORS WITH TSC1 OR TSC2 INACTIVATING ALTERATIONS

14-12-2023
INTERIM RESULTS FROM INVESTIGATOR-ASSESSED RESPONSES IN FIRST 40 PATIENTS FROM TSC1 AND TSC2 ARMS DE...
Více zde

AADI BIOSCIENCE REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER 2023 AND PROVIDES CORPORATE UPDATE

08-11-2023
PRECISION1 TRIAL OF NAB-SIROLIMUS IN SOLID TUMORS WITH TSC1 OR TSC2 INACTIVATING ALTERATIONS ON TRAC...
Více zde

AADI BIOSCIENCE TO PARTICIPATE IN JEFFERIES LONDON HEALTHCARE CONFERENCE

06-11-2023
LOS ANGELES , NOV. 6, 2023 /PRNEWSWIRE/ -- AADI BIOSCIENCE, INC. (NASDAQ: AADI), A COMMERCIAL-STAGE ...
Více zde

AADI BIOSCIENCE ANNOUNCES POSTER PRESENTATIONS ON NAB-SIROLIMUS AT THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY (IGCS) 2023 ANNUAL GLOBAL MEETING

19-10-2023
AADI INITIATES  PHASE 2 TRIAL INVESTIGATING THE COMBINATION OF NAB-SIROLIMUS WITH LETROZOLE FOR TH...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-13 01:00:008-KStáhnout
2025-06-13 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-03-28 00:00:0010-KStáhnout
2025-03-27 23:00:0010-KStáhnout
2025-03-26 00:00:008-KStáhnout
2025-03-25 23:00:008-KStáhnout
2025-03-18 00:00:008-KStáhnout
2025-03-17 23:00:008-KStáhnout
2025-03-04 00:00:008-KStáhnout
2025-03-03 23:00:008-KStáhnout
2024-12-20 00:00:008-KStáhnout
2024-12-19 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-09-30 01:00:008-KStáhnout
2024-09-30 00:00:008-KStáhnout
2024-09-19 01:00:008-KStáhnout
2024-09-19 00:00:008-KStáhnout
2024-08-22 01:00:008-KStáhnout
2024-08-22 00:00:008-KStáhnout
2024-08-21 01:00:008-KStáhnout
2024-08-21 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-06-12 01:00:008-KStáhnout
2024-06-12 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-04-04 01:00:008-KStáhnout
2024-04-04 00:00:008-KStáhnout
2024-03-13 00:00:008-KStáhnout
2024-03-13 00:00:0010-KStáhnout
2024-03-12 23:00:008-KStáhnout
2024-03-12 23:00:0010-KStáhnout
2023-12-14 00:00:008-KStáhnout
2023-12-13 23:00:008-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-08 00:00:0010-QStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-07 23:00:0010-QStáhnout
2023-10-02 01:00:008-KStáhnout
2023-10-02 00:00:008-KStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-06-16 01:00:008-KStáhnout
2023-06-16 00:00:008-KStáhnout
2023-05-10 01:00:008-KStáhnout
2023-05-10 01:00:0010-QStáhnout
2023-05-10 00:00:008-KStáhnout
2023-05-10 00:00:0010-QStáhnout
2023-03-29 01:00:0010-KStáhnout
2023-03-29 00:00:0010-KStáhnout
2023-03-28 01:00:008-KStáhnout
2023-03-28 00:00:008-KStáhnout
2023-03-03 00:00:008-KStáhnout
2023-03-02 23:00:008-KStáhnout
2023-01-23 00:00:008-KStáhnout
2023-01-22 23:00:008-KStáhnout
2022-12-07 00:00:008-KStáhnout
2022-12-06 23:00:008-KStáhnout
2022-11-28 00:00:008-KStáhnout
2022-11-27 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-09-22 01:00:008-KStáhnout
2022-09-22 00:00:008-KStáhnout
2022-08-10 01:00:008-KStáhnout
2022-08-10 01:00:0010-QStáhnout
2022-08-10 00:00:008-KStáhnout
2022-08-10 00:00:0010-QStáhnout
2022-06-30 01:00:008-KStáhnout
2022-06-30 00:00:008-KStáhnout
2022-06-17 01:00:008-KStáhnout
2022-06-17 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-03-17 00:00:008-KStáhnout
2022-03-17 00:00:0010-KStáhnout
2022-03-16 23:00:008-KStáhnout
2022-03-16 23:00:0010-KStáhnout
2022-01-20 00:00:008-KStáhnout
2022-01-19 23:00:008-KStáhnout
2021-11-23 00:00:008-KStáhnout
2021-11-22 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-09-20 01:00:008-KStáhnout
2021-09-20 00:00:008-KStáhnout
2021-09-13 01:00:008-KStáhnout
2021-09-13 00:00:008-KStáhnout
2021-09-03 01:00:008-KStáhnout
2021-09-03 00:00:008-KStáhnout
2021-08-27 01:00:008-KStáhnout
2021-08-27 00:00:008-KStáhnout
2021-08-23 01:00:008-KStáhnout
2021-08-23 00:00:008-KStáhnout
2021-08-18 01:00:008-KStáhnout
2021-08-18 00:00:008-KStáhnout
2021-08-11 01:00:008-KStáhnout
2021-08-11 01:00:0010-QStáhnout
2021-08-11 00:00:008-KStáhnout
2021-08-11 00:00:0010-QStáhnout
2021-07-26 01:00:008-KStáhnout
2021-07-26 00:00:008-KStáhnout
2021-06-04 01:00:008-KStáhnout
2021-06-04 00:00:008-KStáhnout
2021-05-20 01:00:008-KStáhnout
2021-05-20 00:00:008-KStáhnout
2021-05-17 01:00:008-KStáhnout
2021-05-17 01:00:0010-QStáhnout
2021-05-17 00:00:008-KStáhnout
2021-05-17 00:00:0010-QStáhnout
2021-04-01 01:00:008-KStáhnout
2021-04-01 00:00:008-KStáhnout
2021-03-11 00:00:008-KStáhnout
2021-03-11 00:00:0010-KStáhnout
2021-03-10 23:00:008-KStáhnout
2021-03-10 23:00:0010-KStáhnout
2021-03-05 00:00:008-KStáhnout
2021-03-04 23:00:008-KStáhnout
2021-02-16 00:00:008-KStáhnout
2021-02-15 23:00:008-KStáhnout
2021-02-01 00:00:008-KStáhnout
2021-01-31 23:00:008-KStáhnout
2021-01-05 00:00:008-KStáhnout
2021-01-04 23:00:008-KStáhnout
2020-12-11 00:00:008-KStáhnout
2020-12-10 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-10 00:00:0010-QStáhnout
2020-11-09 23:00:008-KStáhnout
2020-11-09 23:00:0010-QStáhnout
2020-08-12 01:00:008-KStáhnout
2020-08-12 01:00:0010-QStáhnout
2020-08-12 00:00:008-KStáhnout
2020-08-12 00:00:0010-QStáhnout
2020-08-04 01:00:008-KStáhnout
2020-08-04 00:00:008-KStáhnout
2020-06-25 01:00:008-KStáhnout
2020-06-25 00:00:008-KStáhnout
2020-05-28 01:00:008-KStáhnout
2020-05-28 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-03-16 00:00:008-KStáhnout
2020-03-16 00:00:0010-KStáhnout
2020-03-15 23:00:008-KStáhnout
2020-03-15 23:00:0010-KStáhnout
2020-01-27 00:00:008-KStáhnout
2020-01-26 23:00:008-KStáhnout
2020-01-08 00:00:008-KStáhnout
2020-01-07 23:00:008-KStáhnout
2019-11-07 00:00:008-KStáhnout
2019-11-07 00:00:0010-QStáhnout
2019-11-06 23:00:008-KStáhnout
2019-11-06 23:00:0010-QStáhnout
2019-10-18 01:00:008-KStáhnout
2019-10-18 00:00:008-KStáhnout
2019-10-10 01:00:008-KStáhnout
2019-10-10 00:00:008-KStáhnout
2019-08-08 01:00:008-KStáhnout
2019-08-08 01:00:0010-QStáhnout
2019-08-08 00:00:008-KStáhnout
2019-08-08 00:00:0010-QStáhnout
2019-07-26 01:00:008-KStáhnout
2019-07-26 00:00:008-KStáhnout
2019-06-19 01:00:008-KStáhnout
2019-06-19 00:00:008-KStáhnout
2019-05-16 01:00:008-KStáhnout
2019-05-16 00:00:008-KStáhnout
2019-05-09 01:00:008-KStáhnout
2019-05-09 01:00:0010-QStáhnout
2019-05-09 00:00:008-KStáhnout
2019-05-09 00:00:0010-QStáhnout
2019-04-10 01:00:008-KStáhnout
2019-04-10 00:00:008-KStáhnout
2019-04-04 01:00:008-KStáhnout
2019-04-04 00:00:008-KStáhnout
2019-03-28 00:00:008-KStáhnout
2019-03-27 23:00:008-KStáhnout
2019-03-18 00:00:008-KStáhnout
2019-03-17 23:00:008-KStáhnout
2019-03-07 00:00:0010-KStáhnout
2019-03-06 23:00:0010-KStáhnout
2019-03-05 00:00:008-KStáhnout
2019-03-04 23:00:008-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2018-11-07 00:00:008-KStáhnout
2018-11-07 00:00:0010-QStáhnout
2018-11-06 23:00:008-KStáhnout
2018-11-06 23:00:0010-QStáhnout
2018-08-14 01:00:008-KStáhnout
2018-08-14 01:00:0010-QStáhnout
2018-08-14 00:00:008-KStáhnout
2018-08-14 00:00:0010-QStáhnout
2018-06-27 01:00:008-KStáhnout
2018-06-27 00:00:008-KStáhnout
2018-06-25 01:00:008-KStáhnout
2018-06-25 00:00:008-KStáhnout
2018-06-22 01:00:008-KStáhnout
2018-06-22 00:00:008-KStáhnout
2018-05-29 01:00:008-KStáhnout
2018-05-29 00:00:008-KStáhnout
2018-05-15 01:00:008-KStáhnout
2018-05-15 01:00:0010-QStáhnout
2018-05-15 00:00:008-KStáhnout
2018-05-15 00:00:0010-QStáhnout
2018-04-02 01:00:008-KStáhnout
2018-04-02 00:00:008-KStáhnout
2018-03-15 00:00:0010-KStáhnout
2018-03-14 23:00:0010-KStáhnout
2018-03-13 00:00:008-KStáhnout
2018-03-12 23:00:008-KStáhnout
2018-01-08 00:00:008-KStáhnout
2018-01-07 23:00:008-KStáhnout
2017-12-18 00:00:008-KStáhnout
2017-12-17 23:00:008-KStáhnout
2017-11-14 00:00:008-KStáhnout
2017-11-13 23:00:008-KStáhnout
2017-11-13 00:00:0010-QStáhnout
2017-11-12 23:00:0010-QStáhnout
2017-10-10 01:00:008-KStáhnout
2017-10-10 00:00:008-KStáhnout
2017-08-10 01:00:0010-QStáhnout
2017-08-10 00:00:0010-QStáhnout
2017-08-08 01:00:008-KStáhnout
2017-08-08 00:00:008-KStáhnout
2017-07-31 01:00:008-KStáhnout
2017-07-31 00:00:008-KStáhnout
2017-06-29 01:00:008-KStáhnout
2017-06-29 00:00:008-KStáhnout
2017-05-16 01:00:008-KStáhnout
2017-05-16 00:00:008-KStáhnout
2017-05-15 01:00:0010-QStáhnout
2017-05-15 00:00:0010-QStáhnout
2017-03-17 00:00:008-KStáhnout
2017-03-16 23:00:008-KStáhnout
2017-03-13 00:00:008-KStáhnout
2017-03-12 23:00:008-KStáhnout
2017-03-07 00:00:0010-KStáhnout
2017-03-06 23:00:0010-KStáhnout
2016-11-14 00:00:0010-QStáhnout
2016-11-13 23:00:0010-QStáhnout
2016-08-15 01:00:0010-QStáhnout
2016-08-15 00:00:0010-QStáhnout
2016-05-16 01:00:0010-QStáhnout
2016-05-16 00:00:0010-QStáhnout
2016-03-30 01:00:0010-KStáhnout
2016-03-30 00:00:0010-KStáhnout
2015-11-13 00:00:0010-QStáhnout
2015-11-12 23:00:0010-QStáhnout
2015-08-13 01:00:0010-QStáhnout
2015-08-13 00:00:0010-QStáhnout
2015-05-13 01:00:0010-QStáhnout
2015-05-13 00:00:0010-QStáhnout
2015-02-27 00:00:0010-KStáhnout
2015-02-26 23:00:0010-KStáhnout
2014-11-14 00:00:0010-QStáhnout
2014-11-13 23:00:0010-QStáhnout
2014-08-14 01:00:0010-QStáhnout
2014-08-14 00:00:0010-QStáhnout
2014-05-15 01:00:0010-QStáhnout
2014-05-15 00:00:0010-QStáhnout
2014-03-31 01:00:0010-KStáhnout
2014-03-31 00:00:0010-KStáhnout
2013-11-14 00:00:0010-QStáhnout
2013-11-13 23:00:0010-QStáhnout
2013-08-14 01:00:0010-QStáhnout
2013-08-14 00:00:0010-QStáhnout
2013-05-15 01:00:0010-QStáhnout
2013-05-15 00:00:0010-QStáhnout
2013-03-28 00:00:0010-KStáhnout
2013-03-27 23:00:0010-KStáhnout
2012-11-14 00:00:0010-QStáhnout
2012-11-13 23:00:0010-QStáhnout
2012-08-14 01:00:0010-QStáhnout
2012-08-14 00:00:0010-QStáhnout
2012-05-15 01:00:0010-QStáhnout
2012-05-15 00:00:0010-QStáhnout
2012-03-30 01:00:0010-KStáhnout
2012-03-30 00:00:0010-KStáhnout
2011-11-14 00:00:0010-QStáhnout
2011-11-13 23:00:0010-QStáhnout
2011-08-15 01:00:0010-QStáhnout
2011-08-15 00:00:0010-QStáhnout
2011-05-16 01:00:0010-QStáhnout
2011-05-16 00:00:0010-QStáhnout
2011-03-31 01:00:0010-KStáhnout
2011-03-31 00:00:0010-KStáhnout
2010-11-15 00:00:0010-QStáhnout
2010-11-14 23:00:0010-QStáhnout
2010-08-13 01:00:0010-QStáhnout
2010-08-13 00:00:0010-QStáhnout
2010-05-17 01:00:0010-QStáhnout
2010-05-17 00:00:0010-QStáhnout
2010-03-31 01:00:0010-KStáhnout
2010-03-31 00:00:0010-KStáhnout
2009-11-16 00:00:0010-QStáhnout
2009-11-15 23:00:0010-QStáhnout
2009-08-14 01:00:0010-QStáhnout
2009-08-14 00:00:0010-QStáhnout
2009-05-15 01:00:0010-QStáhnout
2009-05-15 00:00:0010-QStáhnout
2009-03-31 01:00:0010-KStáhnout
2009-03-31 00:00:0010-KStáhnout
2008-11-12 00:00:0010-QStáhnout
2008-11-11 23:00:0010-QStáhnout
preloader